Drug · DIN 02253186
NUVARING
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 1, 2022; first marketed December 2, 2004.
- Drug Identification Number (DIN)
- 02253186
- Company (DIN owner)
- Organon Canada Inc.Kirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Ring (Slow-Release)
- Route
- Vaginal
- Therapeutic class (ATC)
- Vaginal ring with progestogen and estrogen G02BB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ETONOGESTREL | 11.4 MG | |
| ETHINYL ESTRADIOL | 2.6 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 26, 2021: NOC 25543New Drug Submission (NDS) · Change in product ownership
- February 10, 2011: NOC 12054New Drug Submission (NDS) · Manufacturer name change
- February 24, 2009: NOC 10056New Drug Submission (NDS) · Manufacturer name change
- May 11, 2004: NOC 2880New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “nuvaring”. A notice may cover another product or only some lots: read it to see what it covers.
- NUVARING (etonogestrel / ethinyl estradiol slow release vaginal ring) - New Usage Restrictions - For the PublicJuly 31, 2014 · Drugs · Product safety
- NUVARING (etonogestrel / ethinyl estradiol slow release vaginal ring) - New Usage Restrictions - For Health ProfessionalsJuly 31, 2014 · Drugs · Product safety